Brendan is an Investigator in Epidemiology at the Centers for Epidemiology and Environmental Health at Brown University. He received his PhD in molecular epidemiology from the Kirby Institute at UNSW Australia in 2015. Since then, Brendan has completed postdoctoral training at the National Drug and Alcohol Research Centre (NDARC), UNSW Australia and the Research Centre of the Centre hospitalier de l’Université de Montréal (CRCHUM). His research interests are centered at the intersection of HIV and hepatitis C virus, overdose prevention, and harm reduction for people who use drugs.
| Singleton, Alyson L., Marshall, Brandon D.L., Bessey, S., Harrison, Matthew T., Galvani, Alison P., Yedinak, Jesse L., Jacka, Brendan P., Goodreau, Steven M., Goedel, William C. "Network structure and rapid HIV transmission among people who inject drugs: A simulation-based analysis." Epidemics, vol. 34, 2021, pp. 100426. |
| Jacka BP, Goldman JE, Yedinak JL, Bernstein E, Hadland SE, Buxton JA, Sherman SG, Biello KB, Marshall BDL. "A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial." Trials, vol. 21, no. 1, 2020, pp. 976. |
| Høj SB, Jacka B, Minoyan N, Bussière P, Bruneau J. "Deconstructing the 'cheque effect': Short-term changes in injection drug use after receiving income assistance, and associated factors." Addiction, 2020. |
| Jacka, Brendan P., Phipps, Emily, Marshall, Brandon D.L. "Drug use during a pandemic: convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs." International Journal of Drug Policy, vol. 83, 2020, pp. 102895. |
| Jacka B, Beaudoin F, Li Y, Nimaja E, Yedinak J, Samuels E, Marshall BDL. "Objective Outcome Measures in Randomized Clinical Trials of Interventions to Reduce Risk of Opioid Overdose Following Discharge From the Emergency Department: Utility of Administrative Data Linkage." Journal of Addiction Medicine, 2020. |
| Jacka B, Larney S, Degenhardt L, Janjua N, Høj S, Krajden M, Grebely J, Bruneau J. "Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada." Am J Public Health, vol. 110, no. 1, 2020, pp. 45-50. |
| Picard J, Jacka B, Høj S, Laverdière É, Cox J, Roy É, Bruneau J. "Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs." AIDS and Behavior, 2020. |
| Gaur, Dhruv S., Jacka, Brendan P., Green, Traci C., Samuels, Elizabeth A., Hadland, Scott E., Krieger, Maxwell S., Yedinak, Jesse L., Marshall, Brandon D.L. "US drug overdose mortality: 2009–2018 increases affect young people who use drugs." International Journal of Drug Policy, vol. 85, 2020, pp. 102906. |
| Bartlett SR, Applegate TL, Jacka BP, Martinello M, Lamoury FM, Danta M, Bradshaw D, Shaw D, Lloyd AR, Hellard M, Dore GJ, Matthews GV, Grebely J. "A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015." Journal of the International AIDS Society, vol. 22, no. 2, 2019, pp. e25222. |
| Høj SB, Jacka B, Minoyan N, Artenie AA, Bruneau J. "Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs." International Journal of Drug Policy, 2019. |
| Catlett B, Lamoury FMJ, Bajis S, Hajarizadeh B, Martinez D, Mowat Y, Cunningham PH, Jacka BP, Cloherty GA, Marks P, Dore GJ, Grebely J, Applegate TL. "Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study." Journal of viral hepatitis, 2019. |
| Jacka B, Larance B, Copeland J, Burns L, Farrell M, Jackson E, Degenhardt L. "Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia." Substance Abuse, 2019, pp. 1-7. |
| Artenie AA, Minoyan N, Jacka B, Høj S, Jutras-Aswad D, Roy É, Gauvin L, Zang G, Bruneau J. "Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs." CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol. 191, no. 17, 2019, pp. E462-E468. |
| Jacka, Brendan, Roy, Élise, Høj, Stine, Minoyan, Nanor, Artenie, Andreea Adelina, Zang, Geng, Jutras‐Aswad, Didier, Bruneau, Julie. "Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada." Journal of Viral Hepatitis, 2019. |
| Makarenko I, Artenie A, Hoj S, Minoyan N, Jacka B, Zang G, Barlett G, Jutras-Aswad D, Martel-Laferriere V, Bruneau J. "Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?." International Journal of Drug Policy, 2019. |
| Jacka B, Kemp R, Degenhardt L, Peacock A, Clare P, Bruno R, Dev A, Sotade O, Larance B. "Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015." Drug and Alcohol Review, vol. 38, no. 2, 2019, pp. 159-168. |
| Griffiths S, Jacka B, Degenhardt L, Murray SB, Larance B. "Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users." Drug and Alcohol Review, vol. 37, no. 5, 2018, pp. 664-670. |
| Jacka B, Bray BC, Applegate TL, Marshall BDL, Lima VD, Hayashi K, DeBeck K, Raghwani J, Harrigan PR, Krajden M, Montaner JSG, Grebely J Senior. "Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach." Journal of viral hepatitis, vol. 25, no. 1, 2017, pp. 28-36. |
| Bartlett SR, Grebely J, Eltahla AA, Reeves JD, Howe AYM, Miller V, Ceccherini-Silberstein F, Bull RA, Douglas MW, Dore GJ, Harrington P, Lloyd AR, Jacka B, Matthews GV, Wang GP, Pawlotsky JM, Feld JJ, Schinkel J, Garcia F, Lennerstrand J, Applegate TL. "Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review." Hepatology communications, vol. 1, no. 5, 2017, pp. 379-390. |
| Jacka B, Peacock A, Degenhardt L, Bruno R, Clare P, Kemp R, Dev A, Larance B. "Trends in PIEDs use among male clients of needle-syringe programs in Queensland, Australia; 2007-2015." International Journal of Drug Policy, vol. 46, 2017, pp. 74-78. |
| Montoya V, Olmstead A, Tang P, Cook D, Janjua N, Grebely J, Jacka B, Poon AF, Krajden M. "Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing." Infection, Genetics and Evolution, vol. 43, 2016, pp. 329-37. |
| Bartlett SR, Jacka B, Bull RA, Luciani F, Matthews GV, Lamoury FM, Hellard ME, Hajarizadeh B, Teutsch S, White B, Maher L, Dore GJ, Lloyd AR, Grebely J, Applegate TL. "HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection." Infection, Genetics and Evolution, vol. 37, 2016, pp. 252-8. |
| Jacka B, Applegate T, Poon AF, Raghwani J, Harrigan PR, DeBeck K, Milloy MJ, Krajden M, Olmstead A, Joy JB, Marshall BD, Hayashi K, Pybus OG, Lima VD, Magiorkinis G, Montaner J, Lamoury F, Dore GJ, Wood E, Grebely J. "Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada." Journal of Hepatology, vol. 64, no. 6, 2016, pp. 1247-55. |
| Bradshaw D, Raghwani J, Jacka B, Sacks-Davis R, Lamoury F, Down I, Prestage G, Applegate TL, Hellard M, Sasadeusz J, Dore GJ, Pybus OG, Matthews GV, Danta M. "Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men." PLoS ONE, vol. 11, no. 9, 2016, pp. e0162002. |
| Olmstead AD, Joy JB, Montoya V, Luo I, Poon AF, Jacka B, Lamoury F, Applegate T, Montaner J, Khudyakov Y, Grebely J, Cook D, Harrigan PR, Krajden M. "A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events." Infection, Genetics and Evolution, vol. 33, 2015, pp. 101-9. |
| Lamoury FM, Bartlett S, Jacka B, Hajarizadeh B, Grebely J, Matthews GV, Dore GJ, Applegate TL. "Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types." The Journal of molecular diagnostics : JMD, vol. 17, no. 5, 2015, pp. 583-9. |
| Cunningham EB, Jacka B, DeBeck K, Applegate TL, Harrigan PR, Krajden M, Marshall BD, Montaner J, Lima VD, Olmstead AD, Milloy MJ, Wood E, Grebely J. "Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada." Drug and Alcohol Dependence, vol. 152, 2015, pp. 272-6. |
| Lamoury FM, Jacka B, Bartlett S, Bull RA, Wong A, Amin J, Schinkel J, Poon AF, Matthews GV, Grebely J, Dore GJ, Applegate TL. "The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis." PLoS ONE, vol. 10, no. 7, 2015, pp. e0131437. |
| Jacka B, Applegate T, Krajden M, Olmstead A, Harrigan PR, Marshall B, DeBeck K, Milloy MJ, Lamoury F, Pybus OG, Lima VD, Magiorkinis G, Montoya V, Montaner J, Joy J, Woods C, Dobrer S, Dore GJ, Poon AF, Grebely J. "Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada." Hepatology, vol. 60, no. 5, 2014, pp. 1571-1580. |
| Jacka B, Lamoury F, Simmonds P, Dore GJ, Grebely J, Applegate T. "Sequencing of the Hepatitis C Virus: A Systematic Review." PLoS ONE, vol. 8, no. 6, 2013, pp. e67073. |
| Baleriola C, Johal H, Robertson P, Jacka B, Whybin R, Taylor P, Rawlinson WD. "Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens." Cell and tissue banking, vol. 13, no. 2, 2012, pp. 251-8. |
| Baleriola C, Johal H, Jacka B, Chaverot S, Bowden S, Lacey S, Rawlinson W. "Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -20°C and -70°C." Journal of clinical microbiology, vol. 49, no. 9, 2011, pp. 3163-7. |
| Dolan K, Larney S, Jacka B, Rawlinson W. "Presence of hepatitis C virus in syringes confiscated in prisons in Australia." Journal of gastroenterology and hepatology, vol. 24, no. 10, 2009, pp. 1655-7. |
| Year | Degree | Institution |
|---|---|---|
| 2015 | PhD | University of New South Wales |
| Postdoctoral Research Associate | Brown University, School of Public Health, epidemiology | 2019- | Providence, Rhode Island, USA |
| Postdoctoral Research Fellow | Université de Montréal, Centre de recherche du CHUM | 2017-2019 | Montréal, Quebec, Canada |
Lilienfeld Postdoctoral Prize Paper Award Finalist, Society for Epidemiology Research (2019)
Soutien pour la présentation à un colloque/Travel award, Institut universitaire sur les dépendances (2018)
Postdoctoral Fellowship, Canadian Network on Hepatitis C (CanHepC) (2017-2019)
Postdoctoral Training Fellowship, Fonds de recherche du Québec – Santé (2017-2019)
Travel Support Scholarship, 16th ISVHLD Global Hepatitis Summit (2018)
Best postdoctoral researcher poster, Canadian Symposium on HCV (2018)
Travel Support Scholarship, Australiasian Conference on Viral Hepatitis (2014)
Australian Postgraduate Award, UNSW Sydney (2012-2014)
| Name | Title |
|---|---|
| Beaudoin, Francesca | Associate Professor of Emergency Medicine, Associate Professor of Epidemiology, Associate Professor of Health Services, Policy and Practice |
| Chan, Philip | Associate Professor of Medicine, Associate Professor of Behavioral and Social Sciences |
| Goedel, William | Assistant Professor of Epidemiology (Research) |
| Marshall, Brandon | Associate Professor of Epidemiology |
| Samuels, Elizabeth | Assistant Professor of Emergency Medicine |
